T1	Participants 36 62	multisite clinical trials.
T2	Participants 88 97	multisite
T3	Participants 713 735	clinical trial results
T4	Participants 877 917	interrater reliability training sessions
T5	Participants 995 1034	Phase II multisite clinical drug trial.
